- Home
- CTOR vs CATO Comparison
CTOR vs CATO Comparison
Compare CTOR & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOR
- CATO
- Stock Information
- Founded
- CTOR 2021
- CATO 1946
- Country
- CTOR United States
- CATO United States
- Employees
- CTOR N/A
- CATO N/A
- Industry
- CTOR
- CATO Clothing/Shoe/Accessory Stores
- Sector
- CTOR
- CATO Consumer Discretionary
- Exchange
- CTOR NYSE
- CATO Nasdaq
- Market Cap
- CTOR 126.2M
- CATO 101.5M
- IPO Year
- CTOR N/A
- CATO N/A
- Fundamental
- Price
- CTOR $1.55
- CATO $4.47
- Analyst Decision
- CTOR Strong Buy
- CATO
- Analyst Count
- CTOR 1
- CATO 0
- Target Price
- CTOR $6.00
- CATO N/A
- AVG Volume (30 Days)
- CTOR 87.9K
- CATO 74.8K
- Earning Date
- CTOR 08-12-2024
- CATO 11-14-2024
- Dividend Yield
- CTOR N/A
- CATO 14.98%
- EPS Growth
- CTOR N/A
- CATO N/A
- EPS
- CTOR N/A
- CATO N/A
- Revenue
- CTOR N/A
- CATO $678,865,000.00
- Revenue This Year
- CTOR N/A
- CATO N/A
- Revenue Next Year
- CTOR N/A
- CATO N/A
- P/E Ratio
- CTOR N/A
- CATO N/A
- Revenue Growth
- CTOR N/A
- CATO N/A
- 52 Week Low
- CTOR $1.53
- CATO $4.27
- 52 Week High
- CTOR $49.00
- CATO $8.58
- Technical
- Relative Strength Index (RSI)
- CTOR N/A
- CATO 37.72
- Support Level
- CTOR N/A
- CATO $4.43
- Resistance Level
- CTOR N/A
- CATO $4.65
- Average True Range (ATR)
- CTOR 0.00
- CATO 0.17
- MACD
- CTOR 0.00
- CATO -0.01
- Stochastic Oscillator
- CTOR 0.00
- CATO 25.97
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.